Single-page consumer information sheets designed to replace the extensive documentation currently included with medications are being tested by the FDA as part of the organization’s Safe Use Initiative, according to an article in the online edition of the Wall Street Journal.

If adopted, the standards "would require clear instructions on dose and timing and state in simple terms the purpose of the drug—such as ‘for high blood pressure’ —unless the patient prefers that it not appear," according to the story.

The FDA is also encouraging medical professionals and pharmacists to counsel patients about proper consumption of medications. And this month the National Consumers League launches its Medication Adherence Campaign to support the same effort.